COVIDAR - International Registry on Arrhythmias in COVID-19

Status: Unknown status
Location: See all (5) locations...
Study Type: Observational [Patient Registry]
SUMMARY

BACKGROUND AND RATIONALE: There is very limited literature available on the arrhythmia occurrence in the context of an infection by the SARS-CoV2 virus. On the other hand, treatment strategies against the SARS-CoV2 virus may carry a risk of QTc prolongation and pro-arrhythmia/sudden death which may be amplified by concomitant use of other QTc-prolonging drugs and/or ion disbalances. COVIDAR is an international initiative to monitor the occurrence of arrhythmic events in the context of the SARS-CoV2 infection, to identify potential modifiable predisposing factors to reduce their incidence and to inform the best arrhythmia management options in this patient population. MAIN OBJECTIVE: To describe the incidence and type of arrhythmic events in the context of the SARS-CoV2 infection. STUDY DESIGN: patient registry (observational). Patients will not undergo any additional investigations. Only data that is generated during routine clinical care will be collected. STUDY POPULATION: Patients admitted to the hospital highly suspected of or with confirmed COVID-19.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: No
View:

• Patients admitted with highly suspected/confirmed infection with SARS-CoV-2.

Locations
Other Locations
Belgium
Antwerp University Hospital
Antwerpen
Italy
Istituto Auxologico Italiano, IRCCS
Milan
Netherlands
Amsterdam UMC
Amsterdam
Spain
Hospital Clinic of Barcelona
Barcelona
United Kingdom
St. Georges University Hospitals
London
Contact Information
Primary
Elena Arbelo, MD, PhD
EARBELO@clinic.cat
+34 93 227 5551
Time Frame
Start Date: June 2020
Completion Date: December 2021
Participants
Target number of participants: 10000
Treatments
COVID-19 patients
Patients admitted at one of the participating centres with highly suspected/confirmed infection with SARS-CoV-2.
Sponsors
Collaborators: European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART), European Society of Cardiology, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Istituto Auxologico Italiano, University Hospital, Antwerp, St George's University Hospitals NHS Foundation Trust
Leads: Hospital Clinic of Barcelona

This content was sourced from clinicaltrials.gov

Similar Clinical Trials